Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220004455 220001785 1.69 67.5 Palliative (P) 2018-01-20 2018-01-25 Cytarabine low (10to20mg/m2) IV/SC N N 220026082 CYTARABINE
220004456 220010893 1.47 70.2 Curative (C) 2015-06-12 2015-06-26 LI-1 TRIAL null N 220026084 TRIAL
220004457 220010893 0 null Disease modification (D) null 2013-05-05 Trial Unspecified null null 220026084 TRIAL
220004458 220001786 null null Palliative (P) 2014-01-01 2014-01-03 CYTARABINE N N 220026088 CYTARABINE
220004459 220001786 0 null Curative (C) 2017-08-17 2017-08-18 AML17 TRIAL Y N 220026088 AML17 TRIAL
220004460 220001786 1.57 null null null 2017-11-25 Trial Unspecified N N 220026088 TRIAL
220004461 220001786 null 107 Curative (C) 2017-05-19 2017-05-23 AML17 TRIAL 2 N 220026088 AML17 TRIAL
220004462 220001787 null null Disease modification (D) null 2016-04-15 Cytarabine Low Dose null null 220026093 CYTARABINE
220004463 220001787 null 80.7 null 2017-03-08 2017-03-09 Trial Unspecified 1 null 220026093 TRIAL
220004466 220020270 1.57 66 Curative (C) null 2013-02-07 Trial Unspecified Y null 220026106 TRIAL
220004467 220001788 1.6 58.4 Curative (C) 2016-04-12 2016-04-18 LI-1 TRIAL Y N 220026107 TRIAL
220004468 220001788 1.62 79 Palliative (P) 2017-04-20 2017-04-20 Trial Unspecified Y N 220026107 TRIAL
220004469 220015809 1.68 62.3 Curative (C) 2015-06-03 2015-06-10 Trial Unspecified 1 null 220026110 TRIAL
220004470 220001789 1.5 null Not known (9) 2015-03-26 2015-03-26 Trial Unspecified Y N 220026111 TRIAL
220004471 220010897 1.61 70.6 Curative (C) 2013-11-03 2013-11-03 AML17 TRIAL N N 220026113 AML17 TRIAL
220004472 220010897 1.57 81 null 2016-02-03 2016-02-09 AML17 TRIAL 01 N 220026113 AML17 TRIAL
220004473 220010897 null null Palliative (P) 2016-04-07 2016-04-12 Cytarabine low (10to20mg/m2) IV/SC null null 220026113 CYTARABINE
220004475 220001791 0 0 Palliative (P) 2015-05-11 2015-05-12 Trial Unspecified N N 220026119 TRIAL
220004476 220001791 null 64.4 Curative (C) 2017-08-02 2017-08-02 LI-1 TRIAL 1 null 220026119 TRIAL
220004477 220001791 1.68 74.199 Adjuvant (A) 2015-11-19 2015-11-21 AML17 TRIAL 1 N 220026119 AML17 TRIAL
220004478 220001792 1.68 0 Curative (C) 2016-02-28 2016-03-01 Cytarabine Low Dose 2 N 220026127 CYTARABINE
220004479 220001792 1.68 81.6 Curative (C) 2013-06-28 2013-07-02 Cytarabine Low Dose 02 null 220026127 CYTARABINE
220004480 220001792 1.85 null Curative (C) 2016-07-11 2016-07-12 AML17 TRIAL 02 N 220026127 AML17 TRIAL
220004481 220001792 0 0 Palliative (P) 2016-10-29 2016-10-30 Cytarabine Low Dose 2 N 220026127 CYTARABINE
220004482 220001792 1.8 90.7 Curative (C) 2015-10-04 2015-10-06 AML17 TRIAL 1 N 220026127 AML17 TRIAL
220004483 220001793 null 105 null 2016-11-01 2016-11-01 CYTARABINE 02 null 220026137 CYTARABINE
220004484 220001793 1.82 null null null 2016-01-07 Cytarabine Low Dose N Y 220026137 CYTARABINE
220004485 220015813 1.75 88.8 Disease modification (D) 2014-01-14 2014-01-15 Trial Unspecified Y N 220026144 TRIAL
220004486 220015813 1.82 null Curative (C) 2013-08-09 2013-08-21 AML17 TRIAL N N 220026144 AML17 TRIAL
220004487 220015813 1.52 71 null 2013-09-26 2013-09-26 Trial Unspecified Y N 220026144 TRIAL
220004488 220015813 1.71 70.2 Palliative (P) null 2015-03-02 Cytarabine Low Dose N N 220026144 CYTARABINE
220004489 220001794 1.74 75.4 Palliative (P) 2013-02-11 2013-02-13 Cytarabine Low Dose N N 220026151 CYTARABINE
220004490 220010901 0 0 null 2013-06-29 2013-06-30 Cytarabine low (10to20mg/m2) IV/SC Y N 220026154 CYTARABINE
220004491 220001795 1.92 68.8 Curative (C) 2016-09-30 2016-10-01 AML17 TRIAL 01 N 220026155 AML17 TRIAL
220004492 220001796 0 null Curative (C) 2014-04-24 2014-04-24 Trial Unspecified 1 N 220026157 TRIAL
220004493 220001796 1.79 78.9 Disease modification (D) 2014-08-02 2014-08-02 Cytarabine Low Dose N N 220026157 CYTARABINE
220004494 220001796 1.68 84.6 Palliative (P) 2016-02-19 2016-02-20 Cytarabine Low Dose N Y 220026157 CYTARABINE
220004497 220001797 1.83 80.9 Curative (C) 2015-09-23 2015-11-02 LI-1 TRIAL Y N 220026172 TRIAL
220004498 220010903 null 67.3 Curative (C) 2015-10-25 2015-10-26 Trial Unspecified Y N 220026173 TRIAL
220004499 220010903 1.58 86 null 2015-09-06 2015-09-06 Cytarabine low (10to20mg/m2) IV/SC N N 220026173 CYTARABINE
220004500 220010903 1.73 71.3 Palliative (P) 2015-10-14 2015-10-21 Cytarabine low (10to20mg/m2) IV/SC N N 220026173 CYTARABINE
220004501 220001798 1.63 null Curative (C) 2013-01-08 2013-01-08 AML17 TRIAL 02 N 220026177 AML17 TRIAL
220004502 220001798 null 72.7 Not known (9) 2015-11-19 2015-11-19 AML17 TRIAL 01 N 220026177 AML17 TRIAL
220004503 220001798 1.78 65.8 null 2016-03-02 2016-03-02 Trial Unspecified Y N 220026177 TRIAL
220004504 220001798 1.74 81.8 Curative (C) 2015-11-07 2015-11-07 AML17 TRIAL Y N 220026177 AML17 TRIAL
220004505 220020274 1.7 null null null 2015-11-08 Cytarabine Low Dose null null 220026181 CYTARABINE
220004506 220020274 1.63 58.4 Curative (C) 2015-02-23 2015-02-23 AML17 TRIAL 01 null 220026181 AML17 TRIAL
220004507 220001799 0 69.4 Curative (C) 2016-06-21 2016-06-23 Trial Unspecified Y N 220026185 TRIAL
220004508 220010905 null null null 2013-09-28 2013-10-02 Cytarabine Low Dose N N 220026191 CYTARABINE
220004509 220001800 null null Curative (C) 2017-06-08 2017-06-12 Trial Unspecified 01 null 220026193 TRIAL